Highnoon Laboratories announced Financial Results for the period ended June 30, 2017.
The company’s Net Sales for the period increased by 12.75 percent in the outgoing year, whereas the Profit after Taxation for the Period increased by 17.09 percent.
Comparison of Key Financials
Unconsolidated Profit and Loss Account – For the Six Months Ended
Key Financials
Jan – June, 2017
Jan – Jun, 2016
% Change
Amounts in PKR ‘000
Net Sales
2,857,837,915
2,534,727,427
12.75%
Cost of Sales
1,460,114,048
1,316,732,326
10.89%
Gross Profit
1,397,723,867
1,217,995,101
14.76%
Dist:, Selling and Promo: Expenses
752,833,011
663,745,988
13.42%
Admin: and General Expenses
131,283,442
114,538,893
14.62%
R&D Expenses
1,816,843
1,626,054
11.73%
Other Operating Expenses
44,945,909
38,338,786
17.23%
Operating Profit
466,844,662
399,745,380
16.79%
Other Income
13,730,982
8,406,682
63.33%
Finance Costs
2,353,126
3,271,006
-28.06%
Profit before Taxation
478,222,518
404,881,056
18.11%
Taxation
161,028,030
133,974,995
20.19%
PAT
317,194,488
270,906,061
17.09%
EPS – Basic and Diluted
12.42
10.61
17.06%
Company release on Earnings Report can be accessed here.